July 23rd, 2016
•The goal of this protocol is to use cationic/anionic liposomes with a neuro-targeting peptide as a CNS delivery system to enable siRNA to cross the BBB. The optimization of a delivery system for treatments, like siRNA, would allow for more treatment options for prion and other neurodegenerative diseases.
Tags
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved